Drug Type Small molecule drug |
Synonyms RN 0001, RN-0001, RN0001 |
Target |
Action inhibitors |
Mechanism PPID inhibitors(peptidylprolyl isomerase D inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Pancreatitis | Phase 2 | China | 05 Jan 2026 | |
| Systemic Inflammatory Response Syndrome | Phase 2 | China | 05 Jan 2026 | |
| Acute Kidney Injury | Phase 2 | China | 06 May 2023 | |
| Hepatitis B | Preclinical | China | 30 Jan 2022 | |
| Hepatitis D | Preclinical | China | 30 Jan 2022 | |
| Nerve Degeneration | Preclinical | China | 30 Jan 2022 |





